PowerPlex® 16 System Validation
Abstract
We have improved the manufacturing process for the PowerPlex® 16 System to ensure lot-to-lot spectral consistency and increased ease of use. We show that the amplification results obtained with systems manufactured using the new process are comparable to those obtained using earlier lots manufactured using previous protocols. Because the performance with both PowerPlex® 16 formulations is comparable, users of the PowerPlex® 16 System should see no adverse effects on amplification results.
We have improved the manufacturing process for the PowerPlex® 16 System to ensure lot-to-lot spectral consistency and increased ease of use. We show that the amplification results obtained with systems manufactured using the new process are comparable to those obtained using earlier lots manufactured using previous protocols. Because the performance with both PowerPlex® 16 formulations is comparable, users of the PowerPlex® 16 System should see no adverse effects on amplification results.
See how the Plexor® qPCR System can be used in genotyping assays.
